Menu

Blog

Archive for the ‘genetics’ category: Page 286

Oct 6, 2019

Epigenetics, Epilepsy & Oxidative Stress — The Microbiome Connection

Posted by in categories: biotech/medical, genetics, neuroscience

Gut microbiome affect metabolic and neural diseases through alterations in epigenetic expressions by DNA methylation and miRNA modulations.

Oct 5, 2019

Dr. Kelly Drew — Institute of Arctic Biology — University of Alaska — Human Hibernation Biotech — ideaXme — Ira Pastor

Posted by in categories: aging, bioengineering, biotech/medical, cryonics, genetics, health, life extension, neuroscience, science, space travel

Oct 4, 2019

Everything is Code

Posted by in categories: biotech/medical, genetics, neuroscience

One of the most astonishing revelations might be that information equals reality. In other words, the basis for our material reality is actually immaterial information. Pattern and flow of information is what defines our experiential reality.

Everything boils down to the binary code of Nature. This is a basic tenet of Digital Physics which is the science of information. Nature computes. Deep down we are information technology. We run on genetic, neural and societal codes. Our DNA-based biology is clearly code-theoretic. We are alphabetic all the way down. We communicate intersubjectively mind-to-mind via language-structured exchange of information.

A recent study shows that human speech is transmitted at about 39 bits a sec. Idealist philosopher Terence McKenna used to say that “The world is made of language and if you know the words the world is made of you can make of it whatever you wish.”

Oct 3, 2019

As Silicon Valley faces a tech reckoning, biologists point to the next big opportunity

Posted by in categories: biological, food, genetics

At SynBioBeta, entrepreneurs making plant-based foods and genetically engineered bacteria rallied to promote the idea that it’s biology’s century.

Oct 3, 2019

CRISPR flies have been gene edited so they can eat poison

Posted by in categories: biotech/medical, food, genetics

Scientists at the University of California, Berkeley have used the CRISPR gene-editing tool to give fruit flies an evolutionary advantage they’ve never had before. By making just three small changes to a single gene, the team gave the flies the ability to effectively eat poison and store it in their bodies, protecting themselves from predators in the process.

Milkweed is a common plant that’s toxic to most animals and insects – but the monarch butterfly flies in the face of that plant’s defenses. The bug has evolved the ability to not only thrive on the poisonous plant, but turn it to its own advantage. It stores the toxins in its body, making it poisonous to any predators that might try to eat it.

And now, the UC Berkeley researchers have given fruit flies that ability for the first time. CRISPR has been used to edit the genes of insects, mammals and even humans, but the team says this is the first time a multicellular organism has been edited to endow it with new behaviors and adaptations to the environment. In this case, that means a new diet and a new defense mechanism against predators.

Oct 3, 2019

Is the World Ready for Synthetic People?

Posted by in categories: bioengineering, biotech/medical, computing, food, genetics

Drew Endy almost can’t talk fast enough to convey everything he has to say. It’s a wonderfully complex message filled with nuance, a kind of intricate puzzle box being built by a pioneer of synthetic biology who wants to fundamentally rejigger the living world.

Endy heads a research team at Stanford that is, as he puts it, building genetically encoded computers and redesigning genomes. What that means: he’s trying to engineer life forms to do useful things. Just about anything could come out of this toolkit: new foods, new materials, new medicines. So you are unlikely to find anyone who is more optimistic than he is about the potential for synthetic biology to solve big problems.

That’s what makes Endy so compelling when he worries about how the technology is being developed. Perhaps more than anyone else working in synthetic biology, Endy has tried to hold the community to account.

Oct 2, 2019

CRISPR Gene-Editing May Offer Path To Cure For HIV, First Published Report Shows

Posted by in categories: biotech/medical, genetics, health

CRISPR Gene-Editing Shows Promise As HIV Cure, Research Shows : Shots — Health News Researchers safely used CRISPR gene-editing techniques in a patient with HIV. The research provides evidence the approach may be promising for treating HIV infection.

Oct 2, 2019

Scientists recreate in flies the mutations that let monarch butterfly eat toxic milkweed with impunity

Posted by in categories: bioengineering, biotech/medical, food, genetics, health

The fruit flies in Noah Whiteman’s lab may be hazardous to your health.

Whiteman and his University of California, Berkeley, colleagues have turned perfectly palatable —palatable, at least, to frogs and birds—into potentially poisonous prey that may cause anything that eats them to puke. In large enough quantities, the flies likely would make a human puke, too, much like the emetic effect of ipecac syrup.

That’s because the team genetically engineered the flies, using CRISPR-Cas9 gene editing, to be able to eat milkweed without dying and to sequester its toxins, just as America’s most beloved butterfly, the , does to deter predators.

Oct 2, 2019

Josh Mitteldorf — Cracking the Aging Code

Posted by in categories: evolution, existential risks, genetics, life extension, sustainability

New interview with author and researcher Dr. Josh Mitteldorf who runs the aging research blog Aging Matters.


Interview with author and researcher Dr. Josh Mitteldorf who runs the aging research blog ‘Aging Matters’.

Dr. Josh Mitteldorf is an evolutionary biologist and a long-time contributor to the growing field of aging science. His work in this field has focused on theories of aging. He asks the basic question: why do we age and die?

Continue reading “Josh Mitteldorf — Cracking the Aging Code” »

Oct 1, 2019

‘Revolution’ in prostate cancer care as off-label breast cancer drug doubles survival

Posted by in categories: biotech/medical, genetics

A breast cancer drug has been used to double the survival of men with advanced prostate cancer, becoming the first successful precision medicine for the disease.

Doctors at the Royal Marsden Hospital who conducted the trial say the results amount to a “revolution” in prostate cancer care.

They conducted genetic testing on more than 4,400 patients to identify those with one or more of 15 types of DNA fault.